Clinical Trials of Treatment for Personality Disorders

Psychiatric Clinics of North America

Volumn 31, Issue 3, 2008, Pages 517-526

  Paris, Joel ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; FLUOXETINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OMEGA 3 FATTY ACID; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

BEHAVIOR THERAPY; BORDERLINE STATE; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG FATALITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GROUP THERAPY; HUMAN; LOW DRUG DOSE; PERSONALITY DISORDER; POLYPHARMACY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOANALYSIS; PSYCHODYNAMICS; PSYCHOEDUCATION; PSYCHOTHERAPY; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

BORDERLINE PERSONALITY DISORDER; COMBINED MODALITY THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; MENTAL DISORDERS; PERSONALITY DISORDERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 47049130144     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2008.03.013     Document Type: Review

References (69)

1. Lieb K., Zanarini M.C., Schmahl C., et al. Borderline personality disorder. Lancet 364 9432 (2004) 453-461
2. Paris J. Personality disorders over time (2003), American Psychiatric Press, Washington, DC
3. Skodol A.E., Gunderson J.G., Shea M.T., et al. The collaborative longitudinal personality disorders study (CLPS) overview and implications. J Personal Disord 19 5 (2005) 487-504
4. Zanarini M.C., Frankenburg F.R., Hennen J., et al. The McLean study of adult development (MSAD): overview and implications of the first six years of prospective follow-up. J Personal Disord 19 (2005) 505-523
5. Shea M.T., Pilkonis P.A., Beckham E., et al. Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. Am J Psychiatry 147 (1990) 711-718
6. Mulder R.T. Depression and personality disorder. Curr Psychiatry Rep 6 (2004) 51-57
7. Newton-Howes G., Tyrer P., and Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry 188 (2006) 13-20
8. Linehan M.M. Dialectical behavioral therapy of borderline personality disorder (1993), Guilford, New York
9. Linehan M.M., Armstrong H.E., Suarez A., et al. Cognitive behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 48 (1991) 1060-1064
10. Linehan M.M., Heard H.L., and Armstrong H.E. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 50 (1993) 971-974
11. Koons C.R., Robins C.J., Bishop G.K., et al. Efficacy of dialectical behavior therapy with borderline women veterans: a randomized controlled trial. Behav Ther 32 (2001) 371-390
12. Verheul R., van den Bosch L.M.C., Maarten W.J., et al. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 182 (2003) 135-140
13. Bohus M., Haaf B., Simms T., et al. Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther 42 (2004) 487-499
14. Simpson E.B., Yen S., Costello E., et al. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry 65 (2004) 379-385
15. Linehan M.M., Schmidt III H., Dimeff L.A., et al. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 8 (1999) 279-292
16. Weinberg I., Gunderson J.G., Hennen J., et al. Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. J Personal Disord 20 5 (2006) 482-492
17. Linehan M.M., Comtois K.A., Murray A.M., et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 63 (2006) 757-766
18. Stanley B., Brodsky B., Nelson J.D., and Dulit R. Brief dialectical behavior therapy (DBT-B) for suicidal behavior and non-suicidal self injury. Arch Suicide Res 11 (2007) 337-341
19. Brown G.K., Newman C.F., Charlesworth S.E., et al. An open clinical trial of cognitive therapy for borderline personality disorder. J Personal Disord 18 (2004) 257-271
20. Tyrer P., Thompson S., Schmidt U., et al. Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med 33 (2003) 969-976
21. Davidson K., Norrie J., Tyrer P., et al. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. [comparative study]. J Personal Disord 20 5 (2006) 450-465
22. Davidson K., Tyrer P., Gumley A., et al. A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. J Personal Disord 200 5 (2006) 431-449
23. Palmer S., Davidson K., Tyrer P., et al. The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Personal Disord 20 5 (2006) 466-481
24. Young J.E. Cognitive therapy for personality disorders: a schema focused approach. 3rd edition (1999), Professional Resource Press, Sarasota (FL)
25. Giesen-Bloo J., van Dyck R., Spinhoven P., et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 63 6 (2006) 649-658
26. Blum N., St. John D., Pfohl B., et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry 165 (2008) 468-478
27. Binks C.A., Fenton M., McCarthy L., et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 1 (2006) CD005652
28. Beck A.T., and Freeman A. Cognitive therapy of personality disorders. 2nd edition (2002), Guilford, New York
29. Emmelkamp P.M., Benner A., Kuipers A., et al. Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder. Br J Psychiatry 189 (2006) 60-64
30. Gunderson J.G., Frank A.F., Ronningstam E.F., et al. Early discontinuance of borderline patients from psychotherapy. J Nerv Ment Dis 177 (1989) 38-42
31. Skodol A.E., Buckley P., and Charles E. Is there a characteristic pattern in the treatment history of clinic outpatients with borderline personality?. J Nerv Ment Dis 171 (1983) 405-410
32. Stevenson J., and Meares R. An outcome study of psychotherapy for patients with borderline personality disorder. Am J Psychiatry 149 (1992) 358-362
33. Stevenson J., Meares R., and D'Angelo R. Five-year outcome of outpatient psychotherapy with borderline patients. Psychol Med 35 (2005) 79-87
34. Korner A., Gerull F., Meares R., et al. Borderline personality disorder treated with the conversational model: a replication study. Compr Psychiatry 47 5 (2006) 406-411
35. Bateman A., and Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156 (1999) 1563-1569
36. Bateman A., and Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 158 (2001) 36-42
37. Bateman A., and Fonagy P. Psychotherapy for borderline personality disorder: mentalization based treatment (2004), Oxford University Press, Oxford
38. Bateman A., and Fonagy P. Mentalization-based treatment: a practical guide (2006), John Wiley, New York
39. Fonagy P. An update of on BPD treatment evaluation research in England. Presented to the NIMH international think tank for the more effective treatment of borderline personality disorder. Lincthinum (MD) (December 2004)
40. Clarkin J.F., Levy K.N., Lenzenweger M.F., et al. The personality disorders institute/borderline personality disorder research foundation randomized control trial for borderline personality disorder: rationale, methods, and patient characteristics. J Personal Disord 18 (2004) 52-72
41. Clarkin J.F., Levy K.N., Lenzenweger M.F., et al. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry 164 (2007) 1-8
42. Levy K.N., Clarkin J.F., Yeomans F.E., et al. The mechanisms of change in the treatment of borderline personality disorder with transference-focused psychotherapy. J Clin Psychol 62 4 (2006) 481-501
43. Munroe-Blum H., and Marziali E. A controlled trial of short-term group treatment for borderline personality disorder. J Personal Disord 9 (1995) 190-198
44. Huband N., McMurran M., Evans C., et al. Social problem-solving plus psychoeducation for adults with personality disorder: pragmatic randomised controlled trial. Br J Psychiatry 190 (2007) 307-313
45. Gunderson J.G. Borderline personality disorder: a clinical guide (2001), American Psychiatric Press, Washington, DC
46. Soloff P.H., Cornelius J., George A., et al. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 50 (1993) 377-385
47. Zanarini M.C., and Frankenburg F.R. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 62 (2001) 849-854
48. Zanarini M.C., Frankenburg F.R., and Parachini E.A. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 65 (2004) 903-907
49. Bogenschutz M.P., and Nurnberg G.H. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 65 (2004) 104-109
50. Soler J., Pascual J.C., Campins J., et al. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry 162 (2005) 1221-1224
51. Rinne T., van den Brink W., Wouters L., et al. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 159 (2002) 2048-2054
52. Salzman C., Wolfson A.N., Schatzberg A., et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15 (1995) 23-29
53. Coccaro E.F., and Kavoussi R.J. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 54 (1997) 1081-1088
54. Markowitz P.J. Pharmacotherapy of impulsivity, aggression, and related disorders. In: Hollander E.E., and Stein D.J. (Eds). Impulsivity and Aggression (1995), John Wiley, New York 263-286
55. Cowdry R.W., and Gardner D.L. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 45 (1988) 111-119
56. Soloff P.H., George A., Nathan S., et al. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 9 (1989) 238-246
57. Paris J, Gunderson JG, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorder. Compr Psychiatry 48:145-154.
58. Links P.S., Steiner M., Boiago I., et al. Lithium therapy for borderline patients: preliminary findings. J Personal Disord 4 (1990) 173-181
59. Hollander E., Tracy K.A., Swann A.C., et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 28 (2003) 1186-1197
60. Hollander E., Swann A.C., Coccaro E.F., et al. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 162 (2005) 621-624
61. Kavoussi R.J., and Coccaro E.F. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. J Clin Psychiatry 59 (1998) 676-680
62. Frankenburg F.R., and Zanarini M.C. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 63 (2002) 442-446
63. Tritt K., Nickel C., Lahmann C., et al. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol 19 (2005) 287-291
64. Nickel M.K., Nickel C., Mitterlehner F.O., et al. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry 65 (2004) 1515-1519
65. Loew T.H., Nickel M.K., Muehlbacher M., et al. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 26 (2006) 61-66
66. Zanarini M.C., and Frankenburg F.R. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 160 (2003) 167-169
67. Zanarini M.C., Frankenburg F.R., Khera G.S., et al. Treatment histories of borderline inpatients. Compr Psychiatry 42 (2001) 144-150
68. Oldham J.M., Gabbard G.O., Goin M.K., et al. Practice guideline for the treatment of borderline personality disorder. Am J Psychiatry 158 Suppl (2001) 1-52
69. Binks C.A., Fenton M., McCarthy L., et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev 1 (2006) CD005653